Matthias Spranger

5.2k total citations
70 papers, 4.1k citations indexed

About

Matthias Spranger is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Matthias Spranger has authored 70 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 13 papers in Neurology. Recurrent topics in Matthias Spranger's work include Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Neuroscience and Neuropharmacology Research (10 papers) and Traumatic Brain Injury and Neurovascular Disturbances (9 papers). Matthias Spranger is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Neuroscience and Neuropharmacology Research (10 papers) and Traumatic Brain Injury and Neurovascular Disturbances (9 papers). Matthias Spranger collaborates with scholars based in Germany, United States and Switzerland. Matthias Spranger's co-authors include Stefan Schwab, Werner Hacke, M. Bertram, S. Schwarz, E. Keller, H. Thoenen, Christine E. Bandtlow, Dan Lindholm, Rolf Heumann and A. Aschoff and has published in prestigious journals such as The Journal of Cell Biology, Neurology and Stroke.

In The Last Decade

Matthias Spranger

69 papers receiving 4.0k citations

Peers

Countries citing papers authored by Matthias Spranger

Since Specialization

Citations

This map shows the geographic impact of Matthias Spranger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Spranger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Spranger more than expected).

Fields of papers citing papers by Matthias Spranger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Spranger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Spranger. The network helps show where Matthias Spranger may publish in the future.

Co-authorship network of co-authors of Matthias Spranger

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Spranger. A scholar is included among the top collaborators of Matthias Spranger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Spranger. Matthias Spranger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial 2009 ·Journal of Neurology ·(unknown), N. Strigl‐Pill, (unknown), Cornelia Kornblum, K. Eger, Carsten Wessig, Marcus Deschauer, Frank Breunig, Franz X. Glocker, Stefan Vielhaber, (unknown), Max J. Hilz, Karlheinz Reiners, Wolfgang Müller‐Felber, Eugen Mengel, Matthias Spranger, Benedikt Schoser	196
2	A novel role of interleukin-1-converting enzyme in cytokine-mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases 2007 ·Molecular and Cellular Neuroscience ·Eric Jüttler, (unknown), Matthias Spranger, Victoria Kolb-Bachofen, Christoph V. Suschek	14
3	SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6 2003 ·European Journal of Human Genetics ·Christine Zühlke, Matthias Spranger, S Spranger, (unknown), Michael C. Lanz, (unknown), (unknown), E. Schwinger	29
4	Das Krankheitsbild der myotonen Muskeldystrophie bei Patienten mit großer CTG-Tripletexpansion 1999 ·Der Nervenarzt ·Matthias Spranger, Birgit Janssen, D. Rating, Stephanie Spranger	7
5	Familial Hemiplegic Migraine with Cerebellar Ataxia and Paroxysmal Psychosis 1999 ·European Neurology ·Matthias Spranger, S Spranger, Sibylle G. Schwab, C. Benninger, Martin Dichgans	31
6	Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia 1999 ·Molecular Brain Research ·Frank Gillardon, Matthias Spranger, (unknown), K.‐A. Hossmann	47
7	Moderate Hypothermie zur Behandlung des malignen Mediainfarktes 1999 ·Der Nervenarzt ·Stefan Schwab, Sabine Schwarz, M. Bertram, Matthias Spranger, Werner Hacke	11
8	Heparin inhibits induction of nitric oxide synthase by cytokines in rat brain microvascular endothelial cells 1998 ·Neuroscience Letters ·(unknown), Eric Jüttler, Heinz Krestel, Matthias Spranger	12
9	Craniectomy 1997 ·Neurology ·Stefan Schwab, (unknown), Matthias Spranger, Arnd Dörfler, Friedrich K. Albert, H. H. Steiner, Werner Hacke	77
10	Brain temperature monitoring and modulation in patients with severe MCA infarction 1997 ·Neurology ·Stefan Schwab, Matthias Spranger, A. Aschoff, T. Steiner, Werner Hacke	153
11	Meningeal Involvement in Wegener's Granulomatosis Confirmed and Monitored by Positive Circulating Antineutrophil Cytoplasm in Cerebrospinal Fluid 1997 ·Neurology ·Matthias Spranger, Stefan Schwab, H.‐M. Meinck, (unknown), (unknown), A Breitbart, K. Andrássy	28
12	Three familial cases presenting with an immobile spine. Rigid spine or Emery‐Dreifuss syndrome? 1996 ·Clinical Genetics ·Matthias Spranger, Stephanie Spranger, (unknown), (unknown), H.‐M. Meinck	4
13	Excess glutamate in the cerebrospinal fluid in bacterial meningitis 1996 ·Journal of the Neurological Sciences ·Matthias Spranger, (unknown), Stefan Schwab, Matthias Maiwald, (unknown), Werner Hacke	39
14	Two sisters with Escobar syndrome 1995 ·American Journal of Medical Genetics ·Stephanie Spranger, Matthias Spranger, Hans‐Michael Meinck, Gholamali Tariverdian	30
15	[Therapeutic hypothermia after cerebral ischemia. Theoretical principles and possible clinical applications]. 1994 ·PubMed ·Stefan Schwab, Markus Horn, Matthias Spranger, Werner Hacke	4
16	Induction of Early-Response Genes after Focal Ischemia 1993 ·Cerebrovascular Diseases ·Peter Gass, Matthias Spranger, Marika Kiessling	11
17	Macrophage‐induced cytotoxicity of N‐methyl‐D‐aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines 1992 ·European Journal of Immunology ·Daniela Piani, Matthias Spranger, Karl Frei, Andreas Schaffner, A. Fontana	219
18	Regulation of Nerve Growth Factor (NGF) Synthesis in the Rat Central Nervous System: Comparison between the Effects of Interleukin‐1 and Various Growth Factors in Astrocyte Cultures and in vivo 1990 ·European Journal of Neuroscience ·Matthias Spranger, Dan Lindholm, Christine E. Bandtlow, Rolf Heumann, H. Gnahn, Martina Näher‐Noé, H. Thoenen	318
19	Anomalous inheritance in a kindred with split hand, split foot malformation 1988 ·European Journal of Pediatrics ·Matthias Spranger, (unknown)	22
20	[The problem of surgical therapy of bone cysts at the coxal end of the femur (author's transl)]. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Matthias Spranger	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact